인사] 카나리아바이오, 임상전문가 최승영 본부장 영입

개인 기업 서치펌

인재동향

헬스케어 업계

제약/의료기기/바이오 인재동향

인사] 카나리아바이오, 임상전문가 최승영 본부장 영입

작성자: 정현효

조회: 504 등록일: 2022-09-20

<p> </p><header class="article-view-header" style="box-sizing: inherit; padding: 3.125rem 0px 0px; margin: 0px auto; border-bottom: none; width: 960px; color: rgb(34, 34, 34); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><h3 class="heading" style="box-sizing: inherit; margin: 0px 0px 1.375rem; padding: 0px; font-weight: bolder; color: inherit; text-rendering: optimizelegibility; font-size: 3.125rem; line-height: 1.2; letter-spacing: -0.1em;">[인사] 카나리아바이오, 임상전문가 최승영 본부장 영입</h3><h4 class="subheading" style="box-sizing: inherit; margin: 0px 0px 1.25rem; padding: 0px; font-weight: 300; color: inherit; text-rendering: optimizelegibility; line-height: 1.3; font-size: 1.5625rem; letter-spacing: -0.075em; border-left: none; word-break: normal; overflow-wrap: break-word;">'오레고보맙' 난소암 환자 대상 글로벌 임상3상 관리 주도</h4><div class="info-group" style="box-sizing: inherit; margin: 0px; padding: 1rem 0px; font-size: 0px; border-color: rgb(34, 34, 34); border-width: 7px 0px 1px; border-style: solid;"><article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; width: 319.99px;"><nav role="navigation" style="box-sizing: inherit;"><h3 class="show-for-sr" style="box-sizing: inherit; margin: 0px 0px 0.5rem; padding: 0px; font-weight: 400; color: inherit; text-rendering: optimizelegibility; font-size: 1.9375rem; line-height: 1.4; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">현재위치</h3><ul class="breadcrumbs" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6;"><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="http://www.pharmnews.com/" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;"><i class="icon-home" style="box-sizing: inherit; line-height: inherit;"></i> 홈</a></li><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="https://www.pharmnews.com/news/articleList.html?sc_section_code=S1N43&view_type=sm" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;">의약계소식</a></li><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.875rem; float: left; color: rgb(10, 10, 10); cursor: default; text-transform: uppercase; line-height: 1; letter-spacing: -0.025em;"><a href="https://www.pharmnews.com/news/articleList.html?sc_sub_section_code=S2N118&view_type=sm" style="box-sizing: inherit; background-color: transparent; line-height: inherit; color: rgb(85, 85, 85); text-decoration-line: none; cursor: pointer;">인사</a></li></ul></nav></article> <article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; width: 319.99px;"><ul class="quick-toolkit2" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6; display: flex; flex-wrap: wrap; justify-content: center; text-align: center;"><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool" title="인쇄" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-print" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">바로가기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool sns_clipboard" data-clipboard-text="http://www.pharmnews.com/news/articleView.html?idxno=210480" title="URL주소" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.7125rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">URL</button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool" title="다른 공유" data-open="article-sns" aria-controls="article-sns" aria-haspopup="true" tabindex="0" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-share-alt-o" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">다른 공유 찾기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool scrap-btn" data-idxno="210480" title="기사스크랩" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.85rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s;"><i class="icon-bookmark-o" style="box-sizing: inherit; line-height: inherit;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">기사스크랩하기</span></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool fontsise-btn" value="down" title="본문글씨 줄이기" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.8375rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">가<i class="icon-minus-min" style="box-sizing: inherit; line-height: inherit;"></i></button></li><li style="box-sizing: inherit; margin: 0px; padding: 0px 0.125rem; font-size: inherit; display: block;"><button type="button" class="tool fontsise-btn" value="up" title="본문글씨 키우기" style="box-sizing: inherit; font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 0.8375rem; line-height: 1; margin: 0px; overflow: visible; appearance: button; padding: 0px; border-width: 1px; border-style: solid; border-color: rgb(34, 34, 34); border-radius: 50%; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(34, 34, 34); outline: 0px; width: 30px; height: 30px; cursor: pointer; transition: color 0.25s ease-in 0s, background-color 0.25s ease-out 0s; font-weight: 700;">가<i class="icon-plus-min" style="box-sizing: inherit; line-height: inherit;"></i></button></li></ul></article> <article class="item" style="box-sizing: inherit; display: inline-block; vertical-align: middle; text-align: right; width: 319.99px;"><ul class="infomation" style="box-sizing: inherit; margin: 0px; padding: 0px; list-style: none; line-height: 1.6;"><li style="box-sizing: inherit; margin: 0px; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;">입력 2022.09.20 07:46</li> <li style="box-sizing: inherit; margin: 0px 0px 0px 1.5rem; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;">수정 2022.09.20 07:47</li> <li style="box-sizing: inherit; margin: 0px 0px 0px 1.5rem; padding: 0px; font-size: 0.813rem; display: inline-block; line-height: 1.125; letter-spacing: -0.05em; color: rgb(112, 112, 112); vertical-align: middle;"><span class="show-for-sr" style="box-sizing: inherit; width: 1px; height: 1px; overflow: hidden; clip: rect(0px, 0px, 0px, 0px); position: absolute !important;">기자명</span>이권구 기자</li></ul></article></div></header><section id="articleViewCon" class="article-view-content" style="box-sizing: inherit; display: flex; flex-wrap: wrap; color: rgb(34, 34, 34); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif; font-size: 16px; background-color: rgb(255, 255, 255);"><article class="grid body" style="box-sizing: inherit; flex-basis: 0px; flex-grow: 1; width: auto; max-width: 750px; min-width: 0px; margin: 0px auto; padding: 3.125rem 0px;"><div class="clearfix" style="box-sizing: inherit; margin: 0px; padding: 0px;"></div><article id="article-view-content-div" class="article-veiw-body view-page font-size17" itemprop="articleBody" style="box-sizing: inherit; font-size: 1.063rem; letter-spacing: -0.05em;"><div style="box-sizing: inherit; margin: 0px; padding: 0px; text-align: center;"><figure class="photo-layout image photo_80872 float-center bigsize" data-idxno="80872" data-type="photo" style="box-sizing: inherit; display: inline-block; margin: 0px auto 1rem; position: relative; cursor: pointer; max-width: 960px; float: none !important;"><img alt="" src="https://cdn.pharmnews.com/news/photo/202209/210480_80872_4716.jpg" style="box-sizing: inherit; border-style: none; display: inline-block; vertical-align: middle; max-width: 100%; height: auto;"><figcaption style="box-sizing: inherit; padding: 0px; font-size: 0.8rem; line-height: 1.6em; letter-spacing: -0.05em; color: rgb(145, 145, 145); text-align: left;"></figcaption></figure></div><p style="box-sizing: inherit; margin-top: 1.25em; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">[팜뉴스=이권구 기자]  카나리아바이오가 연구개발 및 임상 인력을 강화하기 위해 임상개발 총괄 최승영 본부장을 영입했다.</p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">최승영 본부장은 서울대 면역학 석사를 거쳐 2년간 연구원으로 재직하고  파렉셀 등 글로벌 CRO에서 임상관리 경력을 쌓은 후 젬백스와  HLB에서 스폰서로 임상관리를 진행한 임상 전문가다. </p><p style="box-sizing: inherit; margin-bottom: 1em; font-size: inherit; line-height: 1.8; text-rendering: optimizelegibility; color: rgb(60, 62, 64); text-align: justify; word-break: normal; overflow-wrap: break-word;">카나리아바이오 나한익 대표이사는 “ 최승영 본부장은 지난 17년간 글로벌 CRO에서 임상을 직접 진행을 했고 또 스폰서 입장에서 CRO 관리를 맡았던 임상 베테랑으로 오레고보맙 신규 난소암 환자 대상 글로벌 임상3상 관리를 주도할 적임자라고 판단했다” 며 영입 배경을 밝혔다. </p></article></article></section><p><span style="color: rgb(60, 62, 64); font-size: inherit; text-align: justify; letter-spacing: -0.05em; background-color: rgb(255, 255, 255); font-family: "Apple SD Gothic Neo", "Helvetica Neue", Roboto, "Nanum Gothic", "Noto Serif KR", "Malgun Gothic", dotum, Arial, sans-serif;">카나리아바이오가 글로벌 임상3상을 진행하고 있는 오레고보맙은 신규 난소암 환자 대상 임상2상에서 무진행생존기간(PFS)을 기존 표준 치료법 대비 30개월이 늘어난 42개월을 보였다.</span></p><p> </p>									<style type='text/css'> p { line-height:270%;}</style>



이전글	유유제약, 천준희 공장장 영입
다음글	인사] LSK Global PS 박병관 상무, 부사장으로 승진

번호	제목	작성자	조회	등록일

286	한화제약, 대웅제약 출신 장홍석 상무 영입	정현효	405	2023-05-22

285	한국아스트라제네카 의학부 총괄에 임재윤 ...	정현효	437	2023-05-08

284	한국유나이티드제약 임원 정기 승진 인사	정현효	410	2023-04-10

283	[인사]일동제약그룹 승진 발령	정현효	453	2023-04-05

282	인사]하나제약 전호성 상무 등 승진	정현효	446	2023-04-05

281	환인제약 이동수 전무, 부사장 승진	정현효	416	2023-04-05

280	한미약품 신임 대표 박재현 부사장…우종수...	정현효	474	2023-04-03

279	유유제약, 박노용 신임 대표 선임… 각자대...	정현효	529	2023-03-06

278	신신제약, 임직원 승진 인사(2023/1/1)	정현효	487	2023-01-26

277	보령·보령컨슈머헬스 임원 승진·보임 인...	정현효	433	2023-01-26

276	종근당 및 계열사 승진인사(2023/1/1)	정현효	449	2023-01-26

275	한국로슈, 고객 파트너십&전략 총괄에 김주...	정현효	486	2023-01-10

274	안국약품 임원 승진 인사(2023/1/1)	정현효	438	2023-01-06

273	국제약품 승진 인사(2023/1/1)	정현효	463	2023-01-06

272	삼일제약은 2023년 1월 1일부로 임원급 인...	정현효	574	2023-01-01

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10